Mariner, LLC Sangamo Therapeutics, Inc Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.58 - $1.47 $9,533 - $24,162	16,437 New	16,437 $9,000
Q1 2023 May 12, 2023	SELL	$1.66 - $3.67 $2,679 - $5,923	-1,614 Reduced 10.53%	13,716 $24,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $1,598 - $2,925	-577 Reduced 3.63%	15,330 $48,000
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $67,922 - $101,645	15,907 New	15,907 $78,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.